2022 HM12: Outcomes of Treatment of Benign Paroxysmal Positional Vertigo

Measure Description

Percentage of patients aged 18 years and older, who report benign paroxysmal positional vertigo (BPPV)-related symptoms and are screened with a dizziness assessment questionnaire and undergo positional nystagmus testing AND, if diagnosed or identified with BPPV, received a BPPV-related care plan and vestibular intervention(s) or treatment(s) AND who have an improvement in nystagmus or report an improvement in BPPV-related symptoms, and report a meaningful clinically important difference (MCID) improvement of BPPV-related quality of life (QoL).

Denominator

Strata 1: Patients aged 18 years and older with a patient encounter

Strata 2: Patients aged 18 years and older who are screened with a dizziness assessment questionnaire, undergo positional nystagmus testing, and are identified or diagnosed with BPPV

Strata 3: Patients aged 18 years and older who received a BPPV-related care plan and vestibular intervention(s) or treatment(s)

Numerator

Strata 1: Patients who do/do not report BPPV-related symptoms AND if report symptoms are screened with a dizziness assessment questionnaire AND undergo positional nystagmus testing AND are identified or diagnosed with BPPV

Strata 2: Patients who received vestibular intervention(s) or treatment(s) within 30 days of the documented BPPV-related care plan

Strata 3: Patients who report a MCID improvement of BPPV-related QoL

Denominator Exclusions

N/A

Denominator Exceptions

Strata 1: Patient reported BPPV-related symptoms and was evaluated with positional nystagmus testing and declined to complete the dizziness assessment questionnaire.

OR

Patient reported BPPV-related symptoms and completed a dizziness assessment questionnaire and declined to complete the positional nystagmus testing

Strata 2: Patient received a BPPV-related care plan within 60 days of the index event

AND

Patient was referred to a qualified practitioner for vestibular intervention(s) or treatment(s) within 60 days of the index event OR additional vestibular evaluation, referral, intervention(s), or treatment(s) were recommended within 60 days of the index event.

OR

Patient received a BPPV-related care plan within 60 days of the index event AND
Patient declined vestibular intervention(s) or treatment(s).

Strata 3: Patient declined to complete a post-vestibular intervention(s) or treatment(s) dizziness assessment questionnaire within 60 days of the index event..

OR

Patient screened with a dizziness assessment questionnaire and was diagnosed or identified with BPPV in at least one ear but declined vestibular intervention(s) or treatment(s) within 60 days of the index event

Numerator Exclusions

N/A

NQF ID Number

N/A

NQS Domain

Effective Clinical Care

High Priority Measure

Yes

Measure Type

Patient Reported Outcome (PRO)

Includes Telehealth?

Yes

Inverse Measure

No

Proportional Measure

Yes

Continuous Variable Measure

No

Ratio Measure

No

Number of performance rates to be calculated and submitted

3

Risk-Adjusted Status?

No